155 related articles for article (PubMed ID: 34860179)
1. Perioperative changes of FGF23 in patients undergoing surgery for primary hyperparathyroidism.
Fořtová M; Hanousková L; Valkus M; Čepová J; Průša R; Kotaška K
Endocr Connect; 2022 Jan; 11(1):. PubMed ID: 34860179
[TBL] [Abstract][Full Text] [Related]
2. Effects of acute kidney injury and chronic hypoxemia on fibroblast growth factor 23 levels in pediatric cardiac surgery patients.
Hanudel MR; Wesseling-Perry K; Gales B; Ramos G; Campbell V; Ethridge K; Scotti M; Elashoff DA; Alejos J; Reemtsen B; Salusky IB
Pediatr Nephrol; 2016 Apr; 31(4):661-9. PubMed ID: 26525200
[TBL] [Abstract][Full Text] [Related]
3. Renal Clearance of Fibroblast Growth Factor-23 (FGF23) and its Fragments in Humans.
Sharma S; Katz R; Ginsberg C; Bullen A; Vallon V; Thomson S; Moe OW; Hoofnagle AN; de Leeuw PW; Kroon AA; Houben AJHM; Ix JH
J Bone Miner Res; 2022 Jun; 37(6):1170-1178. PubMed ID: 35373859
[TBL] [Abstract][Full Text] [Related]
4. Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure.
van Breda F; Emans ME; van der Putten K; Braam B; van Ittersum FJ; Kraaijenhagen RJ; de Borst MH; Vervloet M; Gaillard CA
PLoS One; 2015; 10(6):e0128994. PubMed ID: 26079688
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of C-terminal FGF23 (cFGF23) are associated with 1-year-mortality in patients undergoing transcatheter aortic valve replacement (TAVR).
Mirna M; Lauten A; Jirak P; Rezar R; Wernly B; Paar V; Felder TK; Hoppe UC; Motloch LJ; Jung C; Alushi B; Lichtenauer M; Salmhofer H
Eur J Intern Med; 2021 Mar; 85():98-107. PubMed ID: 33191056
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 23 (FGF23) and early chronic kidney disease in the elderly.
Chudek J; Kocełak P; Owczarek A; Bożentowicz-Wikarek M; Mossakowska M; Olszanecka-Glinianowicz M; Wiecek A
Nephrol Dial Transplant; 2014 Sep; 29(9):1757-63. PubMed ID: 24729016
[TBL] [Abstract][Full Text] [Related]
7. Phosphate control in reducing FGF23 levels in hemodialysis patients.
Rodelo-Haad C; Rodríguez-Ortiz ME; Martin-Malo A; Pendon-Ruiz de Mier MV; Agüera ML; Muñoz-Castañeda JR; Soriano S; Caravaca F; Alvarez-Lara MA; Felsenfeld A; Aljama P; Rodriguez M
PLoS One; 2018; 13(8):e0201537. PubMed ID: 30086150
[TBL] [Abstract][Full Text] [Related]
8. Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.
Wolf M; Koch TA; Bregman DB
J Bone Miner Res; 2013 Aug; 28(8):1793-803. PubMed ID: 23505057
[TBL] [Abstract][Full Text] [Related]
9. Alterations in regulators of the renal-bone axis, inflammation and iron status in older people with early renal impairment and the effect of vitamin D supplementation.
Christodoulou M; Aspray TJ; Piec I; Fraser WD; Schoenmakers I;
Age Ageing; 2024 May; 53(5):. PubMed ID: 38770543
[TBL] [Abstract][Full Text] [Related]
10. Biological variability of plasma intact and C-terminal FGF23 measurements.
Smith ER; Cai MM; McMahon LP; Holt SG
J Clin Endocrinol Metab; 2012 Sep; 97(9):3357-65. PubMed ID: 22689697
[TBL] [Abstract][Full Text] [Related]
11. Intact FGF23 predicts serum phosphate improvement after combined nicotinamide and phosphate binder treatment in hemodialysis patients.
Egli-Spichtig D; Hamid AK; Arroyo EMP; Ketteler M; Wiecek A; Rosenkranz AR; Pasch A; Lorenz H; Hellmann B; Karus M; Ammer R; Rubio-Aliaga I; Wagner CA
Clin Kidney J; 2023 Oct; 16(10):1622-1633. PubMed ID: 37779856
[TBL] [Abstract][Full Text] [Related]
12. Case Report: Unexplained Mild Hypophosphatemia and Very High Serum FGF23 Concentrations.
Bosman A; Ratsma DM; van der Eerden BC; Zillikens MC
JBMR Plus; 2023 Oct; 7(10):e10790. PubMed ID: 37808399
[TBL] [Abstract][Full Text] [Related]
13. High intact fibroblast growth factor 23 levels associated with low hemoglobin levels in patients on chronic hemodialysis.
Fang YW; Wang JT; Lin TY; Lee CJ; Jang TN; Tsai MH; Liou HH
Front Med (Lausanne); 2023; 10():1098871. PubMed ID: 37081846
[TBL] [Abstract][Full Text] [Related]
14. Renal Phosphate Handling: Independent Effects of Circulating FGF23, PTH, and Calcium.
McKenna MJ; Crowley RK; Twomey PJ; Kilbane MT
JBMR Plus; 2021 Feb; 5(2):e10437. PubMed ID: 33615106
[TBL] [Abstract][Full Text] [Related]
15. C-terminal and intact FGF23 in kidney transplant recipients and their associations with overall graft survival.
Chu C; Elitok S; Zeng S; Xiong Y; Hocher CF; Hasan AA; Krämer BK; Hocher B
BMC Nephrol; 2021 Apr; 22(1):125. PubMed ID: 33832449
[TBL] [Abstract][Full Text] [Related]
16. Effects of dietary phosphate and calcium intake on fibroblast growth factor-23.
Vervloet MG; van Ittersum FJ; Büttler RM; Heijboer AC; Blankenstein MA; ter Wee PM
Clin J Am Soc Nephrol; 2011 Feb; 6(2):383-9. PubMed ID: 21030580
[TBL] [Abstract][Full Text] [Related]
17. Relationship between cFGF23/Klotho ratio and phosphate levels in patients with chronic kidney disease.
Liu Z; Zhou H; Chen X; Chen H; Wang Y; Wang T; Cai L; Hong Y; Ke H; Zheng J
Int Urol Nephrol; 2019 Mar; 51(3):503-507. PubMed ID: 30689182
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 23 concentrations and modifying factors in children from age 12 to 24 months.
Enlund-Cerullo M; Hauta-Alus H; Valkama S; Rosendahl J; Andersson S; Mäkitie O; Holmlund-Suila E
Bone; 2020 Dec; 141():115629. PubMed ID: 32919110
[TBL] [Abstract][Full Text] [Related]
19. C-terminal fragment of fibroblast growth factor 23 improves heart function in murine models of high intact fibroblast growth factor 23.
Hu MC; Reneau JA; Shi M; Takahashi M; Chen G; Mohammadi M; Moe OW
Am J Physiol Renal Physiol; 2024 Apr; 326(4):F584-F599. PubMed ID: 38299214
[TBL] [Abstract][Full Text] [Related]
20. Plasma fibroblast growth factor 23 concentration and iron status. Does the relationship exist in the elderly population?
Bożentowicz-Wikarek M; Kocełak P; Owczarek A; Olszanecka-Glinianowicz M; Mossakowska M; Skalska A; Więcek A; Chudek J
Clin Biochem; 2015 Apr; 48(6):431-6. PubMed ID: 25583093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
